NEJM Group

What NEJM Group does

NEJM Group is the publishing division of the Massachusetts Medical Society, a Massachusetts-incorporated nonprofit, headquartered in Waltham, MA. The organization publishes the New England Journal of Medicine, one of the oldest continuously published medical journals in the world (founded 1812), alongside a portfolio of specialized peer-reviewed digital journals: NEJM Clinician (weekly clinical intelligence), NEJM Evidence (clinical trial design and decision-making), NEJM AI (AI/ML in medicine), and NEJM Catalyst (healthcare delivery transformation). The portfolio also includes NEJM CareerCenter for physician recruitment and NEJM 医学前沿, a Chinese-language platform operated with Shanghai-based Jiahui Medical Research and Education.

The underlying technology consists of a digital publishing platform delivering peer-reviewed medical research and clinical content across multiple web properties (nejm.org, clinician.nejm.org, evidence.nejm.org, ai.nejm.org, catalyst.nejm.org), supported by rigorous editorial and peer-review standards that constitute the company's core technical and reputational differentiator. NEJM Group employs 101-250 staff and distributes content through both direct digital subscriptions via store.nejm.org and worldwide institutional licensing via Ovid Technologies, a Wolters Kluwer company. Recent strategic moves have expanded the model into B2B content licensing to AI platforms, including Abridge (clinical decision support) and Elsevier's LeapSpace (research-grade AI workspace), positioning NEJM's peer-reviewed corpus as reference data inside AI-powered clinical and research workflows.

Revenue mechanics rest on three streams: recurring individual subscriptions to NEJM-branded publications; recurring institutional licensing through Ovid/Wolters Kluwer for healthcare and academic institutions globally; and licensing/royalty arrangements with AI technology partners. The company serves practicing physicians and clinicians, medical researchers, healthcare executives and clinical leaders, and Chinese-language medical professionals. Pricing is not publicly disclosed. The organization is not venture-backed, not publicly traded, and operates under a nonprofit mission aligned with the Massachusetts Medical Society's advocacy for physicians and patients.

Name

NEJM Group

Legal name

Massachusetts Medical Society

Website

https://nejmgroup.org

Company type

Private

Founded year

1812

Operating status

Operating

Headcount range

101–250 employees

Short description

NEJM Group is the nonprofit publishing division of the Massachusetts Medical Society, producing the New England Journal of Medicine and a portfolio of peer-reviewed digital journals serving clinicians, researchers, healthcare executives, and the Chinese medical community worldwide, monetized via subscriptions, institutional licensing, and AI content partnerships.

Ownership category

akta.pro rank

Product category

Medical Publishing

NAICS

Periodical Publishers (513120)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro primary industry

Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)

akta.pro secondary industries

Academic & Scholarly Journals Publishing (Peer-Reviewed) (MPAJABAC), Interdisciplinary & Multidisciplinary Scholarly Publishing (EDAGAFAI)

Keywords

• Medical journal publishing
• Peer-reviewed clinical content
• Physician education subscriptions
• Healthcare research publications
• Clinical decision support content

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Individual Subscriptions: Personal subscriptions to NEJM publications including NEJM, NEJM Clinician, NEJM Evidence, NEJM AI, and NEJM Catalyst available for individual clinicians and physicians.
2. Institutional Licensing: Institutional access to NEJM Group publications distributed worldwide through Ovid Technologies, Inc. (a Wolters Kluwer company). Provides access to NEJM, NEJM Clinician, NEJM Evidence, NEJM AI, NEJM Catalyst, and the NEJM Archive to healthcare institutions and academic organizations.
3. Content Licensing to Technology Partners: NEJM Group content is licensed to third-party platforms including Elsevier's LeapSpace AI workspace and Abridge's clinical decision support system, enabling AI-powered search and clinical documentation with peer-reviewed medical literature.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

NEJM Group publishes a portfolio of peer-reviewed medical journals and digital clinical publications led by the New England Journal of Medicine, the world's most cited medical journal. The company sells individual and institutional subscriptions, licenses peer-reviewed content to AI clinical platforms, and operates specialty digital journals covering clinical evidence, AI in medicine, healthcare delivery, physician career resources, and Chinese-language medical research.

Product overview

NEJM Group is a division of the Massachusetts Medical Society and the publisher of the New England Journal of Medicine, the most trusted and influential source of medical knowledge for over 200 years. The company's product portfolio includes The New England Journal of Medicine as the flagship peer-reviewed journal, alongside specialized digital publications: NEJM Clinician (a weekly digital publication for Internal Medicine clinicians), NEJM Evidence (a monthly digital journal on clinical trial design and decision-making), NEJM AI (a journal covering AI and machine learning in medicine), and NEJM Catalyst (targeting healthcare executives and clinical leaders). The portfolio also includes regional offerings such as NEJM 医学前沿 for the Chinese-language medical community and NEJM CareerCenter for physician employment resources. NEJM Group distributes content through institutional partners including Ovid Technologies for academic and healthcare institution access.

Differentiator

Problem solved

Functional benefit

Brands

• New England Journal of Medicine (NEJM): The most trusted, influential source of new medical knowledge and clinical best practices in the world, published for over 200 years
• NEJM Clinician
• NEJM Evidence
• NEJM AI
• NEJM Catalyst
• NEJM CareerCenter
• NEJM 医学前沿 (NEJM Chinese)

Products and services

• The New England Journal of Medicine (NEJM) The flagship peer-reviewed medical journal of NEJM Group, providing rigorously vetted and compiled medical research for physicians and patients for over 200 years. Features rigorously peer-reviewed research, topical reviews, interactive clinical content and cases.
• NEJM Clinician A weekly digital publication delivering expertly curated and actionable updates in a 30-minute read for Internal Medicine clinicians. Curates content from more than 150 peer-reviewed journals, featuring article types including Journal Watch, Guideline Watch, Drug Watch, and Clinical Conversations.
• NEJM Evidence A monthly digital journal presenting original research and bold ideas in clinical trial design and clinical decision-making, providing context and critical evaluation of methods and results. Features series such as Tomorrow's Trial, Patient Platform, and Stats, STAT!
• NEJM AI A peer-reviewed monthly journal dedicated to research and application of artificial intelligence and machine learning in medicine. Covers clinical AI developments, medical imaging AI, policy perspectives, and provides benchmark data sets and protocols. Also produces the NEJM AI Grand Rounds podcast.
• NEJM Catalyst A digital, peer-reviewed journal and event platform that brings together healthcare executives, clinical leaders, and clinicians to share innovative ideas and practical applications for enhancing value of healthcare delivery. Features a qualified Insights Council and live-streamed events.
• NEJM CareerCenter An employment resources platform for physicians providing automated job alerts, robust search functionality, planning guides, and tools to support professional development and career growth in healthcare.
• NEJM 医学前沿 (NEJM Chinese / Yi Xue Qian Yan)

Quantifiable outcome

• NEJM is the most cited medical journal in the world, demonstrating its unmatched influence in clinical practice and research

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and strategic.

• ElseviercoreTechnology or Integration · 25 June 2026NEJM Group content is licensed to Elsevier's LeapSpace research-grade AI workspace, which draws on 20+ million peer-reviewed articles and books from Elsevier and over 1,000 content licensing partners including NEJM Group. LeapSpace provides traceable citations and transparency features for institutional and academic users.
• AbridgecoreTechnology or Integration · 15 April 2026Multi-year content partnership integrating NEJM peer-reviewed clinical research into Abridge's AI-powered Clinical Decision Support system. The integration enables clinicians to access evidence-based research grounded in patient context during patient encounters through Abridge's ambient documentation workflow, combining real-time clinical evidence with AI-powered clinical notes.
• CIDRAP (Center for Infectious Disease Research and Policy)coreStrategic or Co-development Partner · 17 December 2025NEJM Evidence and CIDRAP launched Public Health Alerts, a new series for rapid communication of important public health data. The collaboration delivers information and early warnings about emerging health threats, enabling swift, informed responses across the U.S. and globally. The first alerts covered influenza virus characteristics and clade Ib mpox virus community transmission.
• Jiahui Medical Research and Education (JMRE)strategicStrategic or Co-development PartnerJiahui Medical Research and Education (JMRE) of Shanghai collaborates with NEJM Group to produce NEJM 医学前沿, a Chinese-language digital platform that translates and delivers NEJM content to the Chinese medical community with local expert commentary from China-based physicians.
• Ovid Technologies/Wolters KluwercoreChannel Partner/ Reseller/ DistributorOvid Technologies, Inc. serves as the worldwide distributor for NEJM Group publications including the New England Journal of Medicine, NEJM Clinician, NEJM Evidence, NEJM AI, NEJM Catalyst, and the NEJM Archive, handling institutional sales and distribution globally.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Wolters Kluwer: Global information services company that distributes NEJM Group content via Ovid and also publishes competing medical and clinical reference content (UpToDate, Lippincott). Both a critical channel partner and an overlapping peer in clinical knowledge publishing.
• Springer Nature: Large-scale academic publisher with Nature Medicine and extensive medical/scientific journal portfolio. Competes for high-impact research submissions and institutional library budgets alongside NEJM Group.
• Wiley: Major academic publisher with significant medical, nursing, and healthcare journal portfolio. Competes for institutional subscriptions and society journal publishing contracts in the medical space.
• Elsevier: Major academic and medical publisher (owner of The Lancet) and operator of the LeapSpace AI workspace that licenses NEJM content. Competes broadly across medical journal publishing while also being a content licensing partner.

Regional players

• Karger Publishers: Specialty medical and scientific publisher with strong European heritage, offering a portfolio of peer-reviewed clinical journals. Comparable peer in medical scholarly publishing though with greater specialty/regional concentration.

Emerging players

• Abridge: AI-powered clinical documentation and decision support company that has entered a multi-year content licensing partnership with NEJM Group. Represents an emerging clinical AI category where NEJM content is embedded, making it a strategic partner and adjacent player in clinical AI knowledge delivery.

Direct peers

• Annals of Internal Medicine (American College of Physicians): Top-tier peer-reviewed internal medicine journal from ACP. Direct competitor to NEJM for internal medicine research, with a similar clinician and academic target audience.
• The Lancet (Elsevier): Flagship general medical journal and specialty portfolio from Elsevier. Directly competes with NEJM as one of the top-tier peer-reviewed medical journals globally, targeting similar clinician and researcher audiences.
• BMJ (British Medical Association): Publisher of The BMJ and a portfolio of clinical specialty journals. Comparable peer offering peer-reviewed medical research with both subscription and open access models targeting practicing clinicians worldwide.
• JAMA Network (American Medical Association): Publisher of JAMA, JAMA Internal Medicine, and a portfolio of specialty peer-reviewed medical journals. Directly competes with NEJM Group for high-impact medical research submissions, clinician readership, and institutional subscriptions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nejmgroup
• YouTubeyoutube.com/nejmvideo
• LinkedInlinkedin.com/company/nejm-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NEJM Group